Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

136 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   1-20190   -   -   -   -   [1]
93 
 2   11c-csar   -   -   -   -   [2]
93,
94 
 3   13-15mg/kg/d ursodeoxycholic   -   -   -   -   [1]
93 
 4   18-22mg/kg/d ursodeoxycholic   -   -   -   -   [1]
93 
 5   3 mg [14c]-a4250 capsule   -   -   -   -   [2]
93,
297 
 6   6 alpha-ethylchenodeoxycholic acid (6-edca), oca, int-747   -   -   -   -   [1]
93 
 7   6-ethylchenodeoxycholic acid   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 8   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 9   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (oca)   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 10   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 11   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (oca)   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 12   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 13   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (oca)   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 14   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 15   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (oca)   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 16   A11ha02   -   -   -   -   [1]
93 
 17   A4250   -   -   -   -   [2]
93,
297 
 18   Abatacept   Abatacept   D03203   [2] CD80, CD86   [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   [24]
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 19   Apd334   -   -   -   -   [4]
93,
96,
97,
269 
 20   Atorvastatin   Atorvastatin   D00258, D00887, D07474   [1] HMGCR   [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   [17]
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 21   Baricitinib   Baricitinib   D10308   [2] JAK1, JAK2   [32] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   [8]
41,
46,
49,
50,
93,
107,
265,
325 
 22   Bcd-085   -   -   -   -   [2]
93,
271 
 23   Bezafibrat   -   -   -   -   [1]
93 
 24   Bezafibrat genericon retard 400 mg   -   -   -   -   [1]
93 
 25   Bezafibrate   Bezafibrate   D01366   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [5]
20,
93,
94,
160,
316 
 26   Bezalip   -   -   -   -   [2]
93,
94 
 27   Budenofalk 3mg   -   -   -   -   [2]
93,
97 
 28   Budesonide   Budesonide   D00246   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [9]
66,
93,
94,
95,
96,
97,
98,
228,
299 
 29   Calcium   Calcium   -   -   -   [24]
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 30   Cilofexor   Cilofexor   -   -   -   [2]
93,
94 
 31   Colchicine   Colchicine   D00570   [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   [3] Gap junction, Pathogenic Escherichia coli infection, Phagosome   [5]
2,
42,
56,
93,
266 
 32   Combination antiviral therapy   -   -   -   -   [1]
93 
 33   Cr845 1.0 mg   -   -   -   -   [1]
93 
 34   Crc (a3384)   -   -   -   -   [2]
93,
297 
 35   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [43]
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 36   Denosumab   Denosumab   D03684   [1] TNFSF11   [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis   [7]
46,
50,
93,
95,
96,
274,
299 
 37   E6011   -   -   -   -   [3]
46,
93,
96 
 38   Edp-305   -   -   -   -   [1]
93 
 39   Edp-305 dose 1   -   -   -   -   [1]
93 
 40   Edp-305 dose 2   -   -   -   -   [1]
93 
 41   Elafibranor   Elafibranor   D11208   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [1]
93 
 42   Elafibranor 120 mg   Elafibranor   D11208   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [1]
93 
 43   Elafibranor 80 mg   Elafibranor   D11208   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [1]
93 
 44   Emtricitabine   Emtricitabine   D01199   -   -   [4]
25,
93,
265,
325 
 45   Emtricitabine (ftc)/tenofovir disoproxil (tdf)   Tenofovir disoproxil   D01982   -   -   [1]
93 
 46   Ezetimibe   Ezetimibe   D01966   [1] NPC1L1   [1] Fat digestion and absorption   [4]
49,
79,
93,
260 
 47   Ezetrol   Ezetimibe   D01966   [1] NPC1L1   [1] Fat digestion and absorption   [2]
93,
260 
 48   Fenofibrate   Fenofibrate   D00565   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [5]
8,
79,
93,
94,
265 
 49   Fenofibrate (insoluble drug delivery-micro particle fenofibrate (idd-p)   Fenofibrate   D00565   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [1]
93 
 50   Ffp104   -   -   -   -   [2]
93,
96 
 51   Fully human monoclonal antibody directed against cxcl10   -   -   -   -   [1]
93 
 52   Fuzhenghuayu   -   -   -   -   [1]
93 
 53   Gft505   -   -   -   -   [1]
93 
 54   Gkt137831   -   -   -   -   [2]
85,
93 
 55   Gsk2330672   Gsk2330672   -   -   -   [1]
93 
 56   High protein high fiber diet   -   -   -   -   [2]
93,
95 
 57   Int-747   -   -   -   -   [1]
93 
 58   Int-747, oca   -   -   -   -   [2]
93,
94 
 59   Liver biopsy   -   -   -   -   [1]
93 
 60   Lum001   -   -   -   -   [3]
93,
94,
297 
 61   Mabthera®   -   -   -   -   [6]
13,
35,
43,
44,
46,
93 
 62   Magnesium   Magnesium   -   -   -   [15]
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 63   Mbx 8025   -   -   -   -   [1]
93 
 64   Mbx-8025   -   -   -   -   [2]
79,
93 
 65   Mbx-8025 10 mg capsule   -   -   -   -   [1]
93 
 66   Mbx-8025 2 mg capsule   -   -   -   -   [1]
93 
 67   Mbx-8025 5 mg capsule   -   -   -   -   [1]
93 
 68   Mesenchymal stem cell   -   -   -   -   [2]
2,
93 
 69   Methionine   Methionine   D00019, D04983   -   -   [6]
34,
75,
84,
93,
229,
300 
 70   Methotrexate   Methotrexate   D00142, D02115   [2] DHFR, DHFR2   [4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   [33]
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 71   Minodronic acid   Minodronic acid   -   -   -   [4]
6,
46,
93,
95 
 72   Modafinil   Modafinil   D01832   -   -   [4]
6,
13,
49,
93 
 73   Moexipril   Moexipril   D00623, D08225   [1] ACE   [4] Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   [1]
93 
 74   Ngm282   -   -   -   -   [2]
93,
94 
 75   Ni-0801   -   -   -   -   [1]
93 
 76   Non-myeloablative hematopoietic stem cell transplantation   -   -   -   -   [1]
93 
 77   Obeticholic acid   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [3]
93,
265,
296 
 78   Obeticholic acid (oca)   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 79   Oca (int-747)   -   -   -   -   [1]
93 
 80   Ocaliva   Obeticholic acid   D09360   [1] NR1H4   [1] Bile secretion   [1]
93 
 81   Op-724   -   -   -   -   [1]
93 
 82   Part 1: ljn452   -   -   -   -   [1]
93 
 83   Part 2: ljn452 dose level 1   -   -   -   -   [1]
93 
 84   Part 2: ljn452 dose level 2   -   -   -   -   [1]
93 
 85   Pentoxifylline   Pentoxifylline   D00501   -   -   [10]
26,
56,
84,
93,
96,
113,
220,
222,
296,
298 
 86   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   [10]
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 87   Pyridoxine   Pyridoxine   D02179, D08454   -   -   [2]
93,
145 
 88   Pyridoxine 10mg   Pyridoxine   D02179, D08454   -   -   [1]
93 
 89   Pyridoxine 10mg bp   Pyridoxine   D02179, D08454   -   -   [1]
93 
 90   Questran   Cholestyramine   -   -   -   [3]
93,
254,
297 
 91   Raltegravir   Raltegravir   D06676   -   -   [4]
13,
26,
93,
265 
 92   Risedronic acid   Risedronic acid   D00942, D03234, D08484   [1] FDPS   [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   [3]
93,
95,
274 
 93   Rituximab   Rituximab   D02994   [1] MS4A1   [1] Hematopoietic cell lineage   [42]
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 94   S-adenosyl-l-methionine   Methionine   D00019, D04983   -   -   [1]
93 
 95   S-adenosyl-methionine (same) capsules   Methionine   D00019, D04983   -   -   [1]
93 
 96   Same   Ademetionine   D07128   -   -   [15]
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 97   Saroglitazar   Saroglitazar   -   -   -   [1]
93 
 98   Saroglitazar magnesium 2 mg   Saroglitazar   -   -   -   [1]
93 
 99   Saroglitazar magnesium 4 mg   Saroglitazar   -   -   -   [1]
93 
 100   Seladelpar   -   -   -   -   [2]
93,
94 
 101   Seladelpar 10 mg   -   -   -   -   [1]
93 
 102   Seladelpar 10 mg capsule   -   -   -   -   [1]
93 
 103   Seladelpar 2 mg capsule   -   -   -   -   [1]
93 
 104   Seladelpar 5 mg capsule   -   -   -   -   [1]
93 
 105   Seladelpar 5-10 mg   -   -   -   -   [1]
93 
 106   Sortis   -   -   -   -   [1]
93 
 107   Sortis 10 mg   -   -   -   -   [1]
93 
 108   Sublimated mare milk   -   -   -   -   [1]
93 
 109   Tauroursodeoxycholic acid   Tauroursodeoxycholic acid   -   -   -   [4]
2,
13,
93,
299 
 110   Tauroursodeoxycholic acid capsules   Tauroursodeoxycholic acid   -   -   -   [1]
93 
 111   Tenofovir   Tenofovir   D06074   -   -   [5]
2,
25,
93,
265,
325 
 112   Tenofovir disoproxil   Tenofovir disoproxil   D01982   -   -   [2]
93,
265 
 113   Tetrathiomolybdate   Tetrathiomolybdate   -   -   -   [3]
85,
93,
171 
 114   Tigecycline   Tigecycline   D01079   -   -   [1]
93 
 115   Truvada and kaletra   -   -   -   -   [1]
93 
 116   Udca   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [3]
93,
94,
97 
 117   Udca (ursodeoxycholic acid)   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [1]
93 
 118   Udca combined probiotics   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [1]
93 
 119   Ursodeoxycholic acid   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [8]
6,
67,
84,
93,
94,
95,
96,
97 
 120   Ursodeoxycholic acid (urso)   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [1]
93 
 121   Ursodeoxycholic acid 300mg capsule   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [1]
93 
 122   Ursodeoxycholic acid 300mg tablet   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [1]
93 
 123   Ursodeoxycholic acid capsules   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [1]
93 
 124   Ursodeoxycholic acid combination of immunosuppressive agents   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [2]
93,
95 
 125   Ursodeoxycholsäure   -   -   -   -   [1]
93 
 126   Ursodiol   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [6]
8,
20,
93,
97,
234,
299 
 127   Ursofalk   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [4]
93,
94,
96,
97 
 128   Ursofalk® 500 mg film-coated tablets   -   -   -   -   [1]
93 
 129   Ursofalk® 500 mg filmtabletten   -   -   -   -   [1]
93 
 130   Ursofalk® capsules   -   -   -   -   [1]
93 
 131   Ustekinumab   Ustekinumab   D09214   [3] IL12A, IL12B, IL23A   [25] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   [15]
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 132   Ustekinumab 180 mg   Ustekinumab   D09214   [3] IL12A, IL12B, IL23A   [25] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   [1]
93 
 133   Ustekinumab 45 mg   Ustekinumab   D09214   [3] IL12A, IL12B, IL23A   [25] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   [1]
93 
 134   Ustekinumab 90 mg   Ustekinumab   D09214   [3] IL12A, IL12B, IL23A   [25] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   [3]
50,
93,
96 
 135   Vitamin d   Vitamin d   -   -   -   [18]
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 136   Zoledronic acid   Zoledronic acid   D01968, D06378, D06379, D08689   [1] FDPS   [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   [9]
6,
13,
46,
93,
95,
96,
274,
299,
333 

Back to top